Even with this partial rebound, Lilly's share price remains roughly 13% below the peak set in late August. Some investors ...
The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below the consensus estimates of $12.1 billion and $1.45, respectively.